Ionis Pharmaceuticals, Inc. Payments to Acquire Short-term Investments
Ionis Pharmaceuticals, Inc. (IONS) reported Payments to Acquire Short-term Investments of $110.16 million for the 3-month period ending 2011-03-31, per its 10-Q filed 2011-05-06.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2011-05-06
- Ionis Pharmaceuticals, Inc. payments to acquire short-term investments for the quarter ending 2011-03-31 was $110.16M, a 12.29% decline year-over-year.
- Ionis Pharmaceuticals, Inc. payments to acquire short-term investments for the quarter ending 2010-12-31 was $100.51M, a 32.85% decline year-over-year.
- Ionis Pharmaceuticals, Inc. payments to acquire short-term investments for the quarter ending 2010-09-30 was $103.47M, a 52.93% decline year-over-year.
- Ionis Pharmaceuticals, Inc. payments to acquire short-term investments for the quarter ending 2010-06-30 was $200.56M.
- Ionis Pharmaceuticals, Inc. payments to acquire short-term investments for fiscal 2010 was $530.14M, a 31.72% decline from fiscal 2009.
- Ionis Pharmaceuticals, Inc. payments to acquire short-term investments for fiscal 2009 was $776.38M, a 60.70% increase from fiscal 2008.
- Ionis Pharmaceuticals, Inc. payments to acquire short-term investments for fiscal 2008 was $483.13M.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2011-03-31 | $110.16M 10-Q · filed 2011-05-06 | $210.67M derived: sum of 2 quarters · filed 2011-05-06 | $314.14M derived: sum of 3 quarters · filed 2011-05-06 | $514.70M derived: sum of 4 quarters · filed 2011-05-06 |
| 2010-12-31 | $100.51M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $203.97M derived: sum of 2 quarters · filed 2011-03-01 | $404.54M derived: sum of 3 quarters · filed 2011-03-01 | $530.14M 10-K · filed 2011-03-01 |
| 2010-09-30 | $103.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $304.03M derived: sum of 2 quarters · filed 2010-11-05 | $429.63M 10-Q · filed 2010-11-05 | $579.31M derived: sum of 4 quarters · filed 2011-05-06 |
| 2010-06-30 | $200.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | $326.16M 10-Q · filed 2010-08-09 | $475.84M derived: sum of 3 quarters · filed 2011-05-06 | $695.67M derived: sum of 4 quarters · filed 2011-05-06 |
| 2010-03-31 | $125.60M 10-Q · filed 2011-05-06 | $275.28M derived: sum of 2 quarters · filed 2011-05-06 | $495.11M derived: sum of 3 quarters · filed 2011-05-06 | |
| 2009-12-31 | $149.68M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $369.51M derived: sum of 2 quarters · filed 2011-03-01 | $776.38M 10-K · filed 2011-03-01 | |
| 2009-09-30 | $219.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $626.70M 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | $406.87M 10-Q · filed 2010-08-09 | |||
| 2008-12-31 | $483.13M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |